Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IKT Inhibikase Therapeutics, Inc.

盘前交易 04-21 04:16:52 EDT

1.90

-0.08

-4.04%

最高1.98	最低1.84	成交量16.28万
今开1.96	昨收1.98	日振幅7.07%
总市值1.41亿	流通市值3,268万	总股本7,434万
成交额30.84万	换手率0.95%	流通股本1,720万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IKT","market":"US","secType":"STK","nameCN":"Inhibikase Therapeutics, Inc.","latestPrice":1.9,"timestamp":1744920000000,"preClose":1.98,"halted":0,"volume":162822,"delay":0,"floatShares":17201336,"shares":74341540,"eps":-1.160578,"marketStatus":"盘前交易","change":-0.08,"latestTime":"04-21 04:16:52 EDT","open":1.96,"high":1.98,"low":1.84,"amount":308443.435073,"amplitude":0.070707,"askPrice":3.04,"askSize":200,"bidPrice":0.76,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.160578,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745242200000},"marketStatusCode":1,"adr":0,"listingDate":1608699600000,"exchange":"NASDAQ","adjPreClose":1.9,"postHourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.9,"latestTime":"17:53 EDT","volume":80,"amount":151.38,"timestamp":1744926797038},"volumeRatio":1.3048220124305774},"requestUrl":"/m/hq/s/IKT/wiki","defaultTab":"wiki","newsList":[{"id":"2528749609","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘急速跳水5.56%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528749609?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:28","pubTimestamp":1744900111,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时28分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下跌5.56%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722283194d8dfd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722283194d8dfd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT","BK4007"],"gpt_icon":0},{"id":"2518327836","title":"Inhibikase Therapeutics, Inc.股价拉升13.07% 市值跌214.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518327836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518327836?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:39","pubTimestamp":1741613989,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时39分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速上涨13.07%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213949a26a27d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213949a26a27d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2517948892","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.76%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517948892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517948892?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:36","pubTimestamp":1741185387,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时36分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨5.76%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223628a260c929&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223628a260c929&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2516637316","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨8.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637316?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:57","pubTimestamp":1741013868,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时57分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅上涨8.91%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032257489637b382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032257489637b382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2514373398","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨7.69%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373398?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:59","pubTimestamp":1740754746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时59分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅上涨7.69%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225906abe0f1bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225906abe0f1bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2514869846","title":"Inhibikase Therapeutics, Inc.盘中异动 大幅拉升6.47%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869846?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:26","pubTimestamp":1740594413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时26分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨6.47%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270226539893d64c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270226539893d64c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2514201535","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201535?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:45","pubTimestamp":1740494723,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时45分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下跌6.85%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224523abdc81ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224523abdc81ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2513722779","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大跌9.09%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513722779?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:35","pubTimestamp":1740407759,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时35分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速跳水9.09%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223559a2521583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223559a2521583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","BK4139","LENZ"],"gpt_icon":0},{"id":"2513158722","title":"Inhibikase Therapeutics, Inc.盘中异动 快速跳水5.21%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513158722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513158722?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:51","pubTimestamp":1740160312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时51分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫5.21%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015152988e0a95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015152988e0a95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2512482759","title":"Inhibikase Therapeutics, Inc.盘中异动 急速拉升6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512482759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512482759?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:55","pubTimestamp":1739984121,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时55分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅上涨6.15%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200055229628e44c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200055229628e44c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IKT","LENZ","BK4139"],"gpt_icon":0},{"id":"2512614891","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.53%报2.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512614891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512614891?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:28","pubTimestamp":1739892524,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时28分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速上涨5.53%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182328449627a274&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182328449627a274&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2511613831","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.38%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511613831","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511613831?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:36","pubTimestamp":1739554601,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时36分，Inhibikase Therapeutics, Inc.股票出现异动，股价大幅拉升5.38%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013641abcf2e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013641abcf2e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2510376115","title":"HC Wainwright & Co.：下调Inhibikase Therapeutics(IKT.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376115","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376115?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:44","pubTimestamp":1739364291,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：下调Inhibikase Therapeutics(IKT.US)评级，由买入调整至中性评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12204448120549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","IKT"],"gpt_icon":0},{"id":"2510980638","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.11%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510980638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510980638?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:40","pubTimestamp":1739209200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时40分，Inhibikase Therapeutics, Inc.股票出现波动，股价急速上涨5.11%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101400198809cd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101400198809cd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2509269427","title":"Inhibikase Therapeutics, Inc.盘中异动 临近午盘快速跳水5.10%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509269427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509269427?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:41","pubTimestamp":1738946511,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时41分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速下挫5.10%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004151abc6475f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208004151abc6475f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2509277462","title":"Inhibikase Therapeutics, Inc.盘中异动 急速拉升5.15%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277462?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:08","pubTimestamp":1738854537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时08分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230857a23bd760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230857a23bd760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","IKT"],"gpt_icon":0},{"id":"2508345791","title":"Inhibikase Therapeutics, Inc.盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508345791?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:41","pubTimestamp":1738680109,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时41分，Inhibikase Therapeutics, Inc.股票出现波动，股价快速拉升5.56%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224149987a4c1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224149987a4c1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2508142840","title":"Inhibikase Therapeutics, Inc.盘中异动 急速跳水5.29%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142840?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:11","pubTimestamp":1738595511,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时11分，Inhibikase Therapeutics, Inc.股票出现波动，股价大幅下跌5.29%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231151961702d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231151961702d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0},{"id":"2507965075","title":"Inhibikase Therapeutics, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965075?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:35","pubTimestamp":1738334146,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时35分，Inhibikase Therapeutics, Inc.股票出现异动，股价急速拉升5.21%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312235469614eb5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312235469614eb5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","IKT"],"gpt_icon":0},{"id":"2507621305","title":"Inhibikase Therapeutics, Inc.股价重挫17.86% 市值跌2849.28万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621305?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:32","pubTimestamp":1738247546,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时32分，Inhibikase Therapeutics, Inc.股票出现异动，股价快速下挫17.86%。Inhibikase Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Inhibikase Therapeutics, Inc.公司简介：Inhibikase Therapeutics Inc 是一家临床阶段制药公司，致力于开发蛋白激酶抑制剂疗法，以改变帕金森病，帕金森病相关疾病和其他 Abelson 酪氨酸激酶疾病的病程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223226a234554c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223226a234554c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IKT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inhibikase.com","stockEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.1983},{"period":"3month","weight":-0.3015},{"period":"6month","weight":-0.108},{"period":"1year","weight":-0.108},{"period":"ytd","weight":-0.4154}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inhibikase Therapeutics, Inc.于2010年6月3日注册为特拉华州公司。该公司是一家临床阶段制药公司，致力于开发针对帕金森氏病或PD以及大脑内外发生的相关疾病的疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.280454},{"month":2,"riseRate":0.6,"avgChangeRate":-0.092117},{"month":3,"riseRate":0.2,"avgChangeRate":0.027077},{"month":4,"riseRate":0,"avgChangeRate":-0.200432},{"month":5,"riseRate":0.75,"avgChangeRate":0.088455},{"month":6,"riseRate":0,"avgChangeRate":-0.283409},{"month":7,"riseRate":0.5,"avgChangeRate":-0.045361},{"month":8,"riseRate":0.5,"avgChangeRate":-0.009087},{"month":9,"riseRate":0,"avgChangeRate":-0.157472},{"month":10,"riseRate":0.5,"avgChangeRate":0.119822},{"month":11,"riseRate":0.75,"avgChangeRate":0.000349},{"month":12,"riseRate":0.5,"avgChangeRate":0.007213}],"exchange":"NASDAQ","name":"Inhibikase Therapeutics, Inc.","nameEN":"Inhibikase Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inhibikase Therapeutics, Inc.,IKT,Inhibikase Therapeutics, Inc.股票,Inhibikase Therapeutics, Inc.股票老虎,Inhibikase Therapeutics, Inc.股票老虎国际,Inhibikase Therapeutics, Inc.行情,Inhibikase Therapeutics, Inc.股票行情,Inhibikase Therapeutics, Inc.股价,Inhibikase Therapeutics, Inc.股市,Inhibikase Therapeutics, Inc.股票价格,Inhibikase Therapeutics, Inc.股票交易,Inhibikase Therapeutics, Inc.股票购买,Inhibikase Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inhibikase Therapeutics, Inc.(IKT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inhibikase Therapeutics, Inc.(IKT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}